Author
Listed:
- Emmanuel Stephen-Victor
(Boston Children’s Hospital
Boston Children’s Hospital)
- Gavin A. Kuziel
(Boston Children’s Hospital
Boston Children’s Hospital
Harvard Medical School
Boston Children’s Hospital)
- Monica Martinez-Blanco
(Boston Children’s Hospital
Boston Children’s Hospital)
- Bat-Erdene Jugder
(Boston Children’s Hospital
Boston Children’s Hospital
AstraZeneca)
- Mehdi Benamar
(Boston Children’s Hospital
Boston Children’s Hospital)
- Ziwei Wang
(Boston Children’s Hospital
Boston Children’s Hospital)
- Qian Chen
(Boston Children’s Hospital
Boston Children’s Hospital)
- Gabriel L. Lozano
(Boston Children’s Hospital
Boston Children’s Hospital
Harvard Medical School
Boston Children’s Hospital)
- Azza Abdel-Gadir
(Boston Children’s Hospital
Boston Children’s Hospital)
- Ye Cui
(Boston Children’s Hospital
Boston Children’s Hospital)
- Jason Fong
(Boston Children’s Hospital
Boston Children’s Hospital)
- Elisa Saint-Denis
(Boston Children’s Hospital)
- Iris Chang
(School of Medicine)
- Kari C. Nadeau
(Harvard T.H. Chan School of Public Health)
- Wanda Phipatanakul
(Boston Children’s Hospital
Boston Children’s Hospital)
- Angela Zhang
(Boston Children’s Hospital
Boston Children’s Hospital)
- Farida Abi Farraj
(Boston Children’s Hospital
Boston Children’s Hospital)
- Faye Holder-Niles
(Boston Children’s Hospital
Boston Children’s Hospital)
- Daniel Zeve
(Boston Children’s Hospital
Boston Children’s Hospital)
- David T. Breault
(Boston Children’s Hospital
Boston Children’s Hospital
Harvard Stem Cell Institute)
- Klaus Schmitz-Abe
(Boston Children’s Hospital
Boston Children’s Hospital
Jackson Health System)
- Rima Rachid
(Boston Children’s Hospital
Boston Children’s Hospital)
- Elena Crestani
(Boston Children’s Hospital
Boston Children’s Hospital)
- Seth Rakoff-Nahoum
(Boston Children’s Hospital
Boston Children’s Hospital
Harvard Medical School
Boston Children’s Hospital)
- Talal A. Chatila
(Boston Children’s Hospital
Boston Children’s Hospital)
Abstract
Tolerance to dietary antigens is critical for avoiding deleterious type 2 immune responses resulting in food allergy (FA) and anaphylaxis1,2. However, the mechanisms resulting in both the maintenance and failure of tolerance to food antigens are poorly understood. Here we demonstrate that the goblet-cell-derived resistin-like molecule β (RELMβ)3,4 is a critical regulator of oral tolerance. RELMβ is abundant in the sera of both patients with FA and mouse models of FA. Deletion of RELMβ protects mice from FA and the development of food-antigen-specific IgE and anaphylaxis. RELMβ disrupts food tolerance through the modulation of the gut microbiome and depletion of indole-metabolite-producing Lactobacilli and Alistipes. Tolerance is maintained by the local production of indole derivatives driving FA protective RORγt+ regulatory T (Treg) cells5 through activation of the aryl hydrocarbon receptor. RELMβ antagonism in the peri-weaning period restores oral tolerance and protects genetically prone offspring from developing FA later in life. Together, we show that RELMβ mediates a gut immune–epithelial circuit regulating tolerance to food antigens—a novel mode of innate control of adaptive immunity through microbiome editing—and identify targetable candidates in this circuit for prevention and treatment of FA.
Suggested Citation
Emmanuel Stephen-Victor & Gavin A. Kuziel & Monica Martinez-Blanco & Bat-Erdene Jugder & Mehdi Benamar & Ziwei Wang & Qian Chen & Gabriel L. Lozano & Azza Abdel-Gadir & Ye Cui & Jason Fong & Elisa Sai, 2025.
"RELMβ sets the threshold for microbiome-dependent oral tolerance,"
Nature, Nature, vol. 638(8051), pages 760-768, February.
Handle:
RePEc:nat:nature:v:638:y:2025:i:8051:d:10.1038_s41586-024-08440-7
DOI: 10.1038/s41586-024-08440-7
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:638:y:2025:i:8051:d:10.1038_s41586-024-08440-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.